Literature DB >> 16227536

Phenotypic variability in familial prion diseases due to the D178N mutation.

J J Zarranz1, A Digon, B Atarés, A B Rodríguez-Martínez, A Arce, N Carrera, I Fernández-Manchola, M Fernández-Martínez, C Fernández-Maiztegui, I Forcadas, L Galdos, J C Gómez-Esteban, A Ibáñez, E Lezcano, A López de Munain, J F Martí-Massó, M M Mendibe, M Urtasun, J M Uterga, N Saracibar, F Velasco, M M de Pancorbo.   

Abstract

BACKGROUND: Between January 1993 and December 2003, 19 patients with familial prion diseases due to the D178N mutation were referred to the regional epidemiological registry for spongiform encephalopathies in the Basque Country in Spain, a small community of some 2,100,000 inhabitants.
METHODS: Ten further patients belonging to the same pedigrees were retrospectively ascertained through neurological or neuropathological records. In four of the patients, the diagnosis was confirmed by analysing DNA obtained from paraffin blocks. In this article, we report on the clinical, genetic, and pathological features of the 23 patients carrying the D178N mutation confirmed by genetic molecular analysis. Haplotyping studies suggest a founder effect among Basque born families, explaining in part this unusually high incidence of the D178N mutation in a small community. Only two patients (8%) lack familial antecedents.
RESULTS: We have observed a phenotypic variability even among homozygous 129MM patients. Our findings challenge the currently accepted belief that MM homozygosity in codon 129 is always related to a fatal familial insomnia (FFI) phenotype. Indeed, seven out of 17 patients with a 129MM genotype in this series presented with a Creutzfeldt-Jakob disease (CJD) clinicopathological picture.
CONCLUSIONS: The considerable clinical and pathological overlapping observed among homozygous 129MM patients favours the view that FFI and CJD178 are the extremes of a spectrum rather than two discrete and separate entities. Other genetic or environmental factors apart from the polymorphism in codon 129 may play a role in determining the phenotypic expression of the D178N mutation in the PRNP gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227536      PMCID: PMC1739400          DOI: 10.1136/jnnp.2004.056606

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia.

Authors:  Y Taniwaki; H Hara; K Doh-Ura; I Murakami; H Tashiro; T Yamasaki; H Shigeto; K Arakawa; E Araki; T Yamada; T Iwaki; J Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei.

Authors:  E Lugaresi; R Medori; P Montagna; A Baruzzi; P Cortelli; A Lugaresi; P Tinuper; M Zucconi; P Gambetti
Journal:  N Engl J Med       Date:  1986-10-16       Impact factor: 91.245

3.  Mutations of the prion protein gene phenotypic spectrum.

Authors:  Gábor G Kovács; Gianriccardo Trabattoni; Johannes A Hainfellner; James W Ironside; Richard S G Knight; Herbert Budka
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

Review 4.  Familial and sporadic fatal insomnia.

Authors:  Pasquale Montagna; Pierluigi Gambetti; Pietro Cortelli; Elio Lugaresi
Journal:  Lancet Neurol       Date:  2003-03       Impact factor: 44.182

5.  Fatal familial insomnia: the first account in a family of Chinese descent.

Authors:  Sian D Spacey; Manuela Pastore; Barbara McGillivray; Jonathan Fleming; Pierluigi Gambetti; Howard Feldman
Journal:  Arch Neurol       Date:  2004-01

6.  Familial prion diseases in the Basque Country (Spain).

Authors:  Juan J Zarranz; Anton Digon; Begoña Atarés; José M Arteagoitia; Nieves Carrera; Iñaki Fernández-Manchola; Manuel Fernández-Martínez; Covadonga Fernández-Maiztegui; Isabel Forcadas; Luis Galdos; Agustín Ibáñez; Elena Lezcano; José F Martí-Massó; María M Mendibe; Miguel Urtasun; Juan M Uterga; Nieves Saracibar; Fernando Velasco; Luis González de Galdeano
Journal:  Neuroepidemiology       Date:  2004-09-24       Impact factor: 3.282

7.  Fatal familial insomnia: clinical and pathologic study of five new cases.

Authors:  V Manetto; R Medori; P Cortelli; P Montagna; P Tinuper; A Baruzzi; G Rancurel; J J Hauw; J J Vanderhaeghen; P Mailleux
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

8.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.

Authors:  L G Goldfarb; R B Petersen; M Tabaton; P Brown; A C LeBlanc; P Montagna; P Cortelli; J Julien; C Vital; W W Pendelbury
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

9.  Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation.

Authors:  E Sforza; P Montagna; P Tinuper; P Cortelli; P Avoni; F Ferrillo; R Petersen; P Gambetti; E Lugaresi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1995-06

10.  Clinical and genetic studies of fatal familial insomnia.

Authors:  A T Reder; A S Mednick; P Brown; J P Spire; E Van Cauter; R L Wollmann; L Cervenàkovà; L G Goldfarb; A Garay; F Ovsiew
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  32 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Early onset fatal familial insomnia with rapid progression in a Chinese family line.

Authors:  Shuiliang Yu; Yunjian Zhang; Shu Li; Man-Sun Sy; Shenggang Sun; Po Tien; Gengfu Xiao
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

3.  Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation.

Authors:  Ana B Rodríguez-Martínez; Miguel A Alfonso-Sánchez; José A Peña; Raquel Sánchez-Valle; Inga Zerr; Sabina Capellari; Miguel Calero; Juan J Zarranz; Marian M de Pancorbo
Journal:  Neurogenetics       Date:  2008-03-18       Impact factor: 2.660

4.  Comparative analysis of gene expression profiles between cortex and thalamus in Chinese fatal familial insomnia patients.

Authors:  Chan Tian; Di Liu; Qing-Lan Sun; Chen Chen; Yin Xu; Hui Wang; Wei Xiang; Hans A Kretzschmar; Wei Li; Cao Chen; Qi Shi; Chen Gao; Jin Zhang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-02-21       Impact factor: 5.590

5.  Clinical findings and diagnosis in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

6.  Moving Beyond Syndromic Classifications in Neurodegenerative Disease: The Example of PLA2G6.

Authors:  Matthis Synofzik; Thomas Gasser
Journal:  Mov Disord Clin Pract       Date:  2016-12-10

Review 7.  Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.

Authors:  Matthis Synofzik; Rebecca Schüle
Journal:  Mov Disord       Date:  2017-02-14       Impact factor: 10.338

Review 8.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  ApoE distribution and family history in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Nicolas von Ahsen; Uta Heinemann; Bettina Meissner; Hans A Kretzschmar; Victor W Armstrong; Inga Zerr
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

10.  Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients.

Authors:  Bo-Yeong Choi; Su Yeon Kim; So-Young Seo; Seong Soo A An; Sangyun Kim; Sang-Eun Park; Seung-Han Lee; Yun-Ju Choi; Sang-Jin Kim; Chi-Kyeong Kim; Jun-Sun Park; Young-Ran Ju
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.